News

The company refused the FDA’s request and will continue shipping its therapy, Elevidys, to Duchenne patients who can still ...
An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.
The U.S. Food and Drug Administration is planning to ask Sarepta Therapeutics to voluntarily stop all shipments of its gene ...
Distribution Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter distribution deals. Fully revised and updated, the report provides ...
In this week's "Adam's Biotech Scorecard," Adam also looks at a new trend: the Wall Street-to-pharma career arc.
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter.
A group of 53 biotech executives and life sciences investors is asking the FDA to refrain from taking actions that would impede patients’ access to the abortion drug mifepristone, urging the agency to ...
53 biotech leaders urge FDA not to restrict mifepristone access over 'fatally flawed' report By Darren Incorvaia Jul 2, 2025 2:14pm mifepristone Food and Drug Administration (FDA) abortion Martin ...
NATO’s Innovation Fund has backed UK-based Portal Biotech as it seeks to strengthen the alliance's defences against biological warfare.
Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere ...